Glossary category
Commercial & Market Intelligence
55 plain-English definitions covering commercial & market intelligence — written for the people who run ambulatory surgery centers. Every term links to its own page with key takeaways and FAQs.
- American Hospital AssociationA national trade and advocacy organization representing hospitals, health systems, and their patients. It lobbies on policy, publishes data and guidance, and maintains coding resources widely referenced in billing and reimbursement.
- Anonymized patient level data (APLD)Individual-patient records, often from claims or electronic health records, stripped of direct identifiers so analysts can study treatment patterns and outcomes without exposing identity. Pharmaceutical and commercial teams license APLD to map patient journeys, prescribing behavior, and market opportunities.
- Case LossCase loss refers to surgical or procedural volume a facility fails to capture, whether through cancellations, no-shows, referral leakage, or scheduling gaps. Because each lost case carries fixed-cost overhead, surgery centers track case loss closely as a driver of unrealized revenue.
- Case retentionCase retention is a facility's ability to keep referred or scheduled cases from being diverted elsewhere, converting referrals into completed procedures. Strong retention depends on convenient scheduling, provider relationships, and smooth intake, directly protecting a surgery center's procedural revenue.
- Community LeaderA community leader is an influential individual, such as a local official, advocate, or organization head, who shapes opinion and engagement within a population. In healthcare outreach and market entry, community leaders help build trust, drive adoption, and inform local strategy.
- Confirmed InsightsIn commercial intelligence and account research, findings about a prospect or market that have been validated against a second source or direct verification rather than left as inference. Confirmed insights drive higher-confidence outreach and territory targeting decisions in sales operations.
- Core-Based Statistical Area (CBSA)A Core-Based Statistical Area (CBSA) is a U.S. Census and OMB geographic unit built around an urban core and the surrounding counties tied to it economically. CMS uses CBSA-based wage indexes to adjust provider payments, making it relevant to reimbursement geography.
- Corporate Advisory BoardsCorporate Advisory Boards are convened groups of external experts, often clinicians or industry leaders, that advise a company on strategy, product direction, or market needs. In healthcare and life sciences, they inform development priorities and must be managed to avoid improper influence on prescribing or purchasing.
- Customer Relationship Management (CRM)Customer Relationship Management (CRM) is software and process for tracking a company's interactions with prospects and clients across the sales lifecycle, centralizing contact data, activity history, and pipeline. In healthcare commercial teams, a CRM organizes outreach to facilities, payers, and referral sources.
- Digital InfluencersDigital influencers are individuals who build engaged online audiences and shape opinions through social media, blogs, or video content. In healthcare and life sciences, brands engage them to raise awareness of conditions, products, or campaigns among targeted patient or professional communities.
- Digital Opinion Leader (DOL)A Digital Opinion Leader (DOL) is a healthcare professional, often a clinician or researcher, who actively shapes medical conversations on digital platforms. Life-sciences companies track and engage DOLs to inform messaging, education, and the dissemination of clinical evidence online.
- Emerging Expert or "Rising Star"An Emerging Expert or "Rising Star" is a clinician or researcher identified in commercial intelligence as gaining influence in a therapeutic area, an early-career key opinion leader whom life-sciences and medical-device firms target for engagement before peak prominence.
- External ExpertsExternal Experts are independent specialists outside an organization engaged for objective advice, such as clinicians advising regulators or consultants informing commercial strategy. In market intelligence, they validate evidence, assess unmet need, and shape product positioning decisions.
- FirmographicsFirmographics are descriptive attributes of organizations, such as size, location, specialty, procedure volume, and ownership, used to segment and target accounts. Vendors use ambulatory surgery center firmographics to prioritize prospects and tailor sales and marketing outreach.
- Group Purchasing Organization (GPO) Award CycleThe recurring competitive process by which a group purchasing organization solicits bids, evaluates suppliers, and awards contracts for product categories over a defined term. Vendors time launches and pricing strategy around these cycles to secure favorable contract positions.
- Group Purchasing Organization (GPO) ListingThe status of a supplier's product being included on a group purchasing organization's contracted catalog, making it available to member facilities at negotiated terms. Securing a listing is a key commercial milestone influencing market access and provider adoption.
- Health Economics and Outcomes Research (HEOR)A discipline that evaluates the clinical, economic, and patient-reported value of healthcare interventions to inform coverage, pricing, and treatment decisions. Pharma and device companies use HEOR evidence to support payer negotiations and demonstrate real-world cost-effectiveness.
- Health Technology Assessment (HTA)Health Technology Assessment (HTA) is a structured evaluation of the clinical effectiveness, safety, cost, and broader social impact of a drug, device, or procedure, used by payers and governments to guide coverage, pricing, and adoption decisions.
- Healthcare EcosystemThe healthcare ecosystem is the interconnected network of providers, payers, patients, suppliers, regulators, and technology vendors whose interactions shape how care is delivered, financed, and governed across the industry, including the flow of data, money, and patients among them.
- HEOR AnalysisHEOR (Health Economics and Outcomes Research) analysis is the study of the costs, value, and real-world results of medical interventions, combining economic modeling and outcomes data to support coverage, pricing, and treatment decisions by payers and manufacturers.
- Hospital AffiliationHospital affiliation is a formal relationship between a physician, practice, or facility and a hospital, granting privileges, referral pathways, or shared resources; for surgery centers, affiliations can influence patient flow, credentialing, and contracting leverage with payers.
- Hospital Referral Region (HRR)A Hospital Referral Region (HRR) is a geographic area defined by the Dartmouth Atlas representing a regional market for tertiary medical care, used to analyze patient referral patterns, utilization variation, and resource allocation across markets.
- Inbound SalesA sales approach that engages prospects who initiate contact, typically after marketing, content, or referrals draw them in, rather than relying on cold outreach. Inbound teams qualify and convert these self-sourced leads, often with shorter cycles and higher intent.
- Key Opinion Leader (KOL)A Key Opinion Leader (KOL) is an influential clinical or scientific expert whose recommendations shape peer behavior and treatment adoption. Pharmaceutical and device companies engage KOLs for advisory input, education, and credible communication of evidence to the broader medical community.
- Key Opinion Leader (KOL) ManagementKey Opinion Leader (KOL) management is the structured process of identifying, profiling, engaging, and maintaining relationships with influential clinical experts. Life science commercial and medical teams use it to coordinate advisory work, speaker programs, and compliant scientific exchange across a product's lifecycle.
- MA-Generated InsightsMA-generated insights are findings produced by medical affairs teams from scientific exchange, advisory boards, and KOL interactions. They capture unmet needs, evidence gaps, and field intelligence that inform research priorities, education strategy, and a product's medical and commercial planning.
- Market AccessMarket access is the set of strategies ensuring a drug, device, or service reaches patients by securing favorable coverage, pricing, and reimbursement from payers. It involves health economics, payer engagement, and demonstrating value to clear barriers to adoption.
- Medical CongressA medical congress is a large professional conference where clinicians and researchers present studies, discuss advances, and exchange knowledge within a specialty. For life science companies, congresses are key venues for data presentation, KOL engagement, and competitive intelligence gathering.
- Mergers & Acquisitions (M&As)Mergers and acquisitions (M&As) are transactions in which healthcare organizations combine or one acquires another, consolidating ownership, operations, or market presence. In the ambulatory surgery center space, private equity and health system roll-ups drive ongoing consolidation activity.
- NBRx (New-to-Brand Prescription)NBRx, or new-to-brand prescription, is a pharmaceutical sales metric counting prescriptions written for patients who are new to a particular brand, whether switching or starting therapy. It signals brand adoption momentum more sensitively than total prescription volume.
- New Prescription Starts (NPS)New Prescription Starts (NPS) is a pharmaceutical commercial metric counting patients newly initiated on a specific drug within a period, distinct from refills. Sales and market teams use it to gauge adoption, prescriber uptake, and the impact of promotional activity.
- NPI Target ListAn NPI target list is a curated set of prescribers or facilities identified by National Provider Identifier numbers, used by pharmaceutical and medical-device sales teams to focus outreach. It pairs the NPI's specialty, location, and prescribing or referral signals to prioritize commercial engagement.
- NRx (New Prescription)NRx, or New Prescription, is a pharmaceutical sales metric counting prescriptions written for the first time within a measurement period, as opposed to refills. Combined with total prescriptions, it helps commercial teams assess a drug's new-patient adoption and prescriber behavior.
- OmnichannelOmnichannel refers to a coordinated strategy that connects multiple communication or engagement channels, such as portal, phone, text, and email, into one seamless experience. In healthcare billing, an omnichannel approach lets patients view estimates, ask questions, and pay across consistent touchpoints.
- Outbound SalesA go-to-market approach in which sales representatives proactively initiate contact with prospective buyers through calls, emails, or outreach sequences, rather than waiting for inbound inquiries. It is common in business-to-business healthcare sales targeting facilities, practices, and revenue-cycle decision-makers.
- OutmigrationThe movement of patients out of a local market or health system to receive care elsewhere, often for specialty or surgical services unavailable nearby. Health systems track outmigration to identify lost volume and revenue, and to guide decisions about adding service lines or facilities.
- Patient JourneyThe full sequence of a patient's interactions with the healthcare system for a given condition, from first symptom and referral through diagnosis, treatment, and follow-up. Mapping the journey helps providers identify friction points, including scheduling, billing, and communication gaps that affect experience and revenue.
- Patient KeepageThe share of patients who remain within a health system or network for their care rather than seeking services elsewhere. The inverse of leakage, keepage measures a system's ability to retain referrals and procedure volume, directly affecting captured revenue.
- Patient LeakageThe loss of patients to out-of-network or competing providers when care could have been delivered within a health system. Leakage represents forgone revenue and disrupted continuity, prompting systems to analyze referral patterns and strengthen retention across service lines.
- Patient OriginationThe point or source from which a patient enters a provider's care, such as a physician referral, emergency department, online search, or marketing channel. Tracking origination helps organizations understand referral flow and the return on investment of acquisition efforts.
- Payer MixThe breakdown of a provider's revenue or volume by insurance source, such as commercial, Medicare, Medicaid, and self-pay. Because reimbursement rates differ sharply by source, a surgery center's payer mix strongly shapes its financial health and case-selection strategy.
- Physician LiaisonA healthcare marketing professional who builds and maintains referral relationships between a facility and referring physicians, gathering feedback and promoting services. For ambulatory surgery centers, liaisons help grow case volume by strengthening surgeon and primary-care referral channels.
- Physician Practice Management GroupA company that provides centralized administrative, financial, and operational services to multiple medical practices, often through ownership or management contracts. These groups consolidate billing, RCM, and back-office functions, and frequently operate or acquire ambulatory surgery centers.
- Physician Relationship Management (PRM) SoftwarePhysician Relationship Management (PRM) software is a CRM-style platform that tracks referral activity, liaison outreach, and engagement with referring providers. Health systems and ambulatory surgery centers use it to analyze referral patterns and grow profitable case volume.
- Primary Service Areas (PSA)Primary Service Areas (PSAs) are the geographic zones, typically defined by ZIP codes, from which a facility draws the bulk of its patients. Health systems and ASCs use PSA analysis for market planning, referral targeting, and competitive positioning.
- Referral NetworkThe interconnected web of clinicians and facilities that direct patients to one another for specialized care. ASCs depend on referral networks from primary care and specialists to sustain surgical case volume and predictable revenue.
- Sales cadenceA sales cadence is a structured, timed sequence of outreach touches, such as calls, emails, and messages, that a sales team follows to engage a prospect. It standardizes follow-up timing and channels to improve conversion.
- Secondary Service Areas (SSA)A Secondary Service Area (SSA) is the broader geographic region beyond a facility's core market from which it draws a smaller, supplemental share of patients. It informs strategic planning, outreach, and market-share analysis.
- Service Line GroupingService line grouping is the practice of organizing clinical activity, encounters, and financial data into defined categories such as orthopedics or cardiology. It enables targeted analysis of volume, profitability, and performance across an organization's distinct service lines.
- Service LinesService lines are groupings of related clinical services organized around a specialty, condition, or patient population, such as orthopedics or GI. Health systems and surgery centers manage them as distinct business units for strategy and budgeting.
- Serviceable Addressable Market (SAM)Serviceable Addressable Market (SAM) is the portion of a total market that a company's products and business model can realistically serve, given its scope and geography. It narrows the broad market to a reachable target segment.
- Serviceable Obtainable Market (SOM)Serviceable Obtainable Market (SOM) is the share of the serviceable addressable market a company can realistically capture near-term, accounting for competition, capacity, and reach. It represents a practical, achievable revenue target rather than the theoretical maximum.
- Share of Voice (SoV)Share of Voice (SoV) is a marketing metric measuring a brand's visibility or advertising presence relative to competitors within a market or channel. Higher SoV generally correlates with greater awareness and market influence among the target audience.
- Total Addressable Market (TAM)The total revenue opportunity available if a product or service captured every potential customer in its market. Healthcare companies use TAM to size demand, prioritize segments, and frame growth potential for investors and strategic planning.
- Total Prescriptions (TRx)A pharmaceutical sales metric counting all prescriptions dispensed for a drug in a period, combining new and refill scripts. Brand teams track TRx to gauge market share, prescriber adoption, and the commercial performance of a product.